DANIEL S FULEIHAN MD FACC NPI 1245226919

NPI Details

Daniel S Fuleihan, MD FACC is a cardiovascular disease internal medicine in Syracuse, NY with 54 years of experience. The provider is an internist who specializes in diseases of the heart and blood vessels and manages complex cardiac conditions such as heart attacks and life-threatening, abnormal heartbeat rhythms. Daniel S Fuleihan, MD FACC NPI is 1245226919. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

1000 E GENESEE ST
STE 300
SYRACUSE, NY
ZIP 13210-892
Phone: (315) 471-1044
Fax: (315) 474-4312

The NPI 1245226919 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only (HCPCS:93010)
• Injection, regadenoson, 0.1 mg (HCPCS:J2785)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Technetium tc-99m sestamibi, diagnostic, per study dose (HCPCS:A9500)
• Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days (HCPCS:93296)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec (HCPCS:G2066)
• Evaluation of cardiac rhythm monitor system, remote up to 30 days (HCPCS:93298)
• Blood test, clotting time (HCPCS:85610)
• Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days (HCPCS:93294)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician (HCPCS:93015)
• Bilirubin level, direct (HCPCS:82248)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Ultrasound of both sides of head and neck blood flow (HCPCS:93880)
• Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
• Nuclear medicine studies of heart muscle at rest and with stress and spect (HCPCS:78452)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days (HCPCS:93295)
• Initial hospital inpatient care per day, typically 30 minutes (HCPCS:99221)
• Programming of dual lead pacemaker system (HCPCS:93280)
• Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days (HCPCS:93244)
• Liver function blood test panel (HCPCS:80076)
• Programming of single lead pacemaker system (HCPCS:93279)
• Electrocardiogram (ecg) 2-day continuous with review by health care professional (HCPCS:93227)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Ultrasound of heart, follow-up (HCPCS:93308)
• Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries (HCPCS:A9555)
• Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional (HCPCS:93228)
• Programming of dual lead implantable defibrillator system (HCPCS:93283)
• Natriuretic peptide (heart and blood vessel protein) level (HCPCS:83880)
• Programming of multiple lead implantable defibrillator system (HCPCS:93284)
• Evaluation of cardiac rhythm monitor system (HCPCS:93291)
• Heart muscle strain imaging (HCPCS:93356)
• Heart muscle strain imaging (HCPCS:93356)
• Nuclear medicine studies of blood flow in heart muscle at rest and with stress (HCPCS:78492)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional (HCPCS:93272)

The enumeration date for this NPI number is 9/27/2005 and was last updated on 4/15/2010.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.